ID   RMS559
AC   CVCL_S640
SY   RMS559/R31
DR   Cosmic; 1718097
DR   Cosmic; 2355958
DR   Wikidata; Q54950715
RX   PubMed=12370270;
RX   PubMed=22142829;
RX   PubMed=23665679;
RX   PubMed=23882450;
CC   Sequence variation: Mutation; HGNC; 3691; FGFR4; Simple; p.Val550Leu (c.1648G>C); Zygosity=Unspecified (PubMed=22142829).
DI   NCIt; C8971; Embryonal rhabdomyosarcoma
DI   ORDO; Orphanet_99757; Embryonal rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 11
//
RX   PubMed=12370270; DOI=10.1172/JCI15634;
RA   Panigrahy D., Singer S., Shen L.Q., Butterfield C.E., Freedman D.A.,
RA   Chen E.J., Moses M.A., Kilroy S., Duensing S., Fletcher C.D.M.,
RA   Fletcher J.A., Hlatky L., Hahnfeldt P., Folkman J., Kaipainen A.;
RT   "PPARgamma ligands inhibit primary tumor growth and metastasis by
RT   inhibiting angiogenesis.";
RL   J. Clin. Invest. 110:923-932(2002).
//
RX   PubMed=22142829; DOI=10.1158/1078-0432.CCR-11-2056;
RA   Shukla N., Ameur N., Yilmaz I., Nafa K., Lau C.-Y., Marchetti A.,
RA   Borsu L., Barr F.G., Ladanyi M.;
RT   "Oncogene mutation profiling of pediatric solid tumors reveals
RT   significant subsets of embryonal rhabdomyosarcoma and neuroblastoma
RT   with mutated genes in growth signaling pathways.";
RL   Clin. Cancer Res. 18:748-757(2012).
//
RX   PubMed=23665679; DOI=10.1038/onc.2013.129;
RA   Sokolowski E., Turina C.B., Kikuchi K., Langenau D.M., Keller C.;
RT   "Proof-of-concept rare cancers in drug development: the case for
RT   rhabdomyosarcoma.";
RL   Oncogene 33:1877-1889(2014).
//
RX   PubMed=23882450; DOI=10.3389/fonc.2013.00183;
RA   Hinson A.R.P., Jones R., Crose L.E.S., Belyea B.C., Barr F.G.,
RA   Linardic C.M.;
RT   "Human rhabdomyosarcoma cell lines for rhabdomyosarcoma research:
RT   utility and pitfalls.";
RL   Front. Oncol. 3:183.1-183.12(2013).
//